Make Yourself Count - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Make Yourself Count
This year, the employment survey will acknowledge the industry's best employees.


Pharmaceutical Technology
Volume 9, Issue 32, pp. 16


Maribel Rios
Pharmaceutical Technology has been the authoritative source of the industry for more than 30 years. One of our unique resources is the annual employment survey, which has been part of this publication for the past 20 years. The article, appearing in the December issue, is more than a salary update; it provides a look into the industry workplace from the perspective of those who know it best. Readers have let us know that they turn to the survey as one of their resources when making hiring decisions or future career plans.

Globalization is leading to big changes in the industry, but one of the most universal topics of interest to professionals worldwide is the current work environment. About 10 years ago, to make the results of the employment survey more comprehensive, we gave the survey an international perspective. This year, we would like to expand on this goal and encourage even greater participation from our readers outside the United States.

We've also added a new segment to this year's survey. Recognizing that high levels of job satisfaction come from good employers, the questionnaire invites participants to nominate their company as one of the "Best Companies to Work for" in the industry. Past survey participants have voiced their opinions about what they enjoy the best about their jobs, and many of these opinions have centered around the job environment at their particular company. This year, we hope to recognize these companies and perhaps inspire new and future employers.

We invite you to click here anytime until Sept. 30 to make yourself count and participate in this important survey. And perhaps you may want to nominate your company as one of the "Best Companies to Work for" in the pharmaceutical industry.

Maribel Rios is a senior editor at Pharmaceutical Technology.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
8%
All of the above.
41%
No government involvement in patient treatment or drug development.
11%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Source: Pharmaceutical Technology,
Click here